Longboard Pharmaceuticals (NASDAQ: ) just reported results for the first quarter of 2024. InvestorPlace Earnings is a project that leverages data from…
Investment Analysts’ price target changes for Friday, May 3rd: Apple (NASDAQ:AAPL) had its target price increased by Monness Crespi & Hardt from $200.00 to $205.00. The firm currently has a buy rating on the stock. Apple (NASDAQ:AAPL) had its target price boosted by JPMorgan Chase & Co. from $210.00 to $225.00. They currently have an […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They currently have a $60.00 target price on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the company’s current price. Other […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research note issued to investors on Friday, Benzinga reports. They currently have a $60.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the stock’s current […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research note issued to investors on Friday, Benzinga reports. They currently have a $60.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the stock’s current […]